CAJ | 학술논문

目的：探讨舒利迭治疗慢性支气管炎急性发作的临床效果。方法：回顾性分析我院2010年1月～2013年3月收治的140例慢性支气管炎急性发作患者的临床病例，按照随机的方法将这140例患者分为治疗组及对照组，每组70例，治疗组患者在常规治疗的基础上加用舒利迭(沙美特罗替卡松粉吸入剂)，对照组患者仅行常规化痰治疗，比较两组患者的治疗效果及不良反应。结果：治疗组患者的临床治疗效果优于对照组(P<0.05)，两组患者间差异具有统计学意义。结论：舒利迭(沙美特罗替卡松粉吸入剂)可有效的治疗慢性支气管炎急性发作，安全性好，不良反应小，值得在临床上推广应用。
목적：탐토서리질치료만성지기관염급성발작적림상효과。방법：회고성분석아원2010년1월～2013년3월수치적140례만성지기관염급성발작환자적림상병례，안조수궤적방법장저140례환자분위치료조급대조조，매조70례，치료조환자재상규치료적기출상가용서리질(사미특라체잡송분흡입제)，대조조환자부행상규화담치료，비교량조환자적치료효과급불량반응。결과：치료조환자적림상치료효과우우대조조(P<0.05)，량조환자간차이구유통계학의의。결론：서리질(사미특라체잡송분흡입제)가유효적치료만성지기관염급성발작，안전성호，불량반응소，치득재림상상추엄응용。
Objective:To investigate the ShuLi idea for treatment of chronic bronchitis acute episodes. Methods:A retrospective analysis from January 2010 to March 2010 were treated 140 cases of patients with chronic bronchitis acute clinical cases, according to random method the 140 patients were divided into treatment group and control group, 70 cases in each group, the treatment group patients on the basis of conventional treatment combined with ShuLi overlapping (salmeterol assigned powder inhalant), control group patients only routine phlegm treatment, compared two groups of patients in the therapeutic effect and adverse reactions. Results:The treatment group patients clinical treatment effect is better than that of control group (P<0.05), statistically significant difference between the two groups of patients. Conclusion:ShuLi overlapping (salmeterol assigned powder inhalant) can be effective for the treatment of chronic bronchitis acute episodes, good safety, small adverse reactions, worthy of popularization and application in clinic.